
Read More
IOL Chemicals With Rs 495 Crore Expansion; Will The Stock See A Re-Rating O...
IOLCP is investing Rs 495 crore to expand Ibuprofen capacity by 50 per cent while entering CDMO and ...

IOLCP is investing Rs 495 crore to expand Ibuprofen capacity by 50 per cent while entering CDMO and ...

This article is authored by Ms Shivani Wagh, Joint Managing Director, Supriya Lifescience Ltd...

The shares of Shilpa Medicare soared 10.47 per cent to Rs 453.25 on BSE after the company announced ...